219 related articles for article (PubMed ID: 38188575)
1. Comparing technology and regulatory landscape of probiotics as food, dietary supplements and live biotherapeutics.
Spacova I; Binda S; Ter Haar JA; Henoud S; Legrain-Raspaud S; Dekker J; Espadaler-Mazo J; Langella P; Martín R; Pane M; Ouwehand AC
Front Microbiol; 2023; 14():1272754. PubMed ID: 38188575
[TBL] [Abstract][Full Text] [Related]
2. Live biotherapeutic products: the importance of a defined regulatory framework.
Cordaillat-Simmons M; Rouanet A; Pot B
Exp Mol Med; 2020 Sep; 52(9):1397-1406. PubMed ID: 32908212
[TBL] [Abstract][Full Text] [Related]
3. Microbiological Testing of Probiotic Preparations.
Zawistowska-Rojek A; Zaręba T; Tyski S
Int J Environ Res Public Health; 2022 May; 19(9):. PubMed ID: 35565098
[TBL] [Abstract][Full Text] [Related]
4. Probiotic foods and drugs: impact of US regulatory status on design of clinical trials.
Hibberd PL; Davidson L
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S137-40; discussion S144-51. PubMed ID: 18181720
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics-Based Tools and Software in Clinical Research: A New Emerging Area.
Bansal P; Arora M; Gupta V; Maithani M
Methods Mol Biol; 2019; 1939():215-230. PubMed ID: 30848464
[TBL] [Abstract][Full Text] [Related]
6. Regulatory categories of probiotics across the globe: a review representing existing and recommended categorization.
Arora M; Baldi A
Indian J Med Microbiol; 2015 Feb; 33 Suppl():2-10. PubMed ID: 25657150
[TBL] [Abstract][Full Text] [Related]
7. The Unregulated Probiotic Market.
de Simone C
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):809-817. PubMed ID: 29378309
[TBL] [Abstract][Full Text] [Related]
8. The US Food and Drug Administration and probiotics: regulatory categorization.
Degnan FH
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S133-6; discussion S144-51. PubMed ID: 18181719
[TBL] [Abstract][Full Text] [Related]
9. Probiotic formulations and applications, the current probiotics market, and changes in the marketplace: a European perspective.
Saxelin M
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S76-9; discussion S144-51. PubMed ID: 18181728
[TBL] [Abstract][Full Text] [Related]
10. The Development of High-Quality Multispecies Probiotic Formulations: From Bench to Market.
Grumet L; Tromp Y; Stiegelbauer V
Nutrients; 2020 Aug; 12(8):. PubMed ID: 32824147
[TBL] [Abstract][Full Text] [Related]
11. The Comparison of Food and Supplement as Probiotic Delivery Vehicles.
Homayoni Rad A; Vaghef Mehrabany E; Alipoor B; Vaghef Mehrabany L
Crit Rev Food Sci Nutr; 2016; 56(6):896-909. PubMed ID: 25117939
[TBL] [Abstract][Full Text] [Related]
12. Bringing a probiotic-containing functional food to the market: microbiological, product, regulatory and labeling issues.
Sanders ME; Huis in't Veld J
Antonie Van Leeuwenhoek; 1999; 76(1-4):293-315. PubMed ID: 10532385
[TBL] [Abstract][Full Text] [Related]
13. Market and product assessment of probiotic/prebiotic-containing functional foods and supplements manufactured in South Africa.
Brink M; Senekal M; Dicks LM
S Afr Med J; 2005 Feb; 95(2):114-9. PubMed ID: 15751206
[TBL] [Abstract][Full Text] [Related]
14. The evidence to support health claims for probiotics.
Farnworth ER
J Nutr; 2008 Jun; 138(6):1250S-4S. PubMed ID: 18492865
[TBL] [Abstract][Full Text] [Related]
15. Probiotic triangle of success; strain production, clinical studies and product development.
Forssten SD; Laitila A; Maukonen J; Ouwehand AC
FEMS Microbiol Lett; 2020 Oct; 367(19):. PubMed ID: 33049046
[TBL] [Abstract][Full Text] [Related]
16. Are Probiotic Really Safe for Humans?
Zawistowska-Rojek A; Tyski S
Pol J Microbiol; 2018; 67(3):251-258. PubMed ID: 30451441
[TBL] [Abstract][Full Text] [Related]
17. Commercial probiotic products in public health: current status and potential limitations.
Liang D; Wu F; Zhou D; Tan B; Chen T
Crit Rev Food Sci Nutr; 2024; 64(19):6455-6476. PubMed ID: 36688290
[TBL] [Abstract][Full Text] [Related]
18. Authenticity of probiotic foods and dietary supplements: A pivotal issue to address.
Fusco V; Fanelli F; Chieffi D
Crit Rev Food Sci Nutr; 2022; 62(25):6854-6871. PubMed ID: 33819118
[TBL] [Abstract][Full Text] [Related]
19. Emerging issues in probiotic safety: 2023 perspectives.
Merenstein D; Pot B; Leyer G; Ouwehand AC; Preidis GA; Elkins CA; Hill C; Lewis ZT; Shane AL; Zmora N; Petrova MI; Collado MC; Morelli L; Montoya GA; Szajewska H; Tancredi DJ; Sanders ME
Gut Microbes; 2023; 15(1):2185034. PubMed ID: 36919522
[TBL] [Abstract][Full Text] [Related]
20. Health claims substantiation for probiotic and prebiotic products.
Sanders ME; Heimbach JT; Pot B; Tancredi DJ; Lenoir-Wijnkoop I; Lähteenmäki-Uutela A; Gueimonde M; Bañares S
Gut Microbes; 2011; 2(3):127-33. PubMed ID: 21646865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
